Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis

Gene
S TairaK Runeberg-Nyman

Abstract

We have expressed the pneumolysin gene of Streptococcus pneumoniae in Bacillus subtilis, both from its own promoter and as a fusion protein. The level of expression of pneumolysin from its own promoter was low. The protein produced was hemolytically active. A higher level of expression (about 10 micrograms/ml of culture) was achieved when either one of two C-terminal fragments (corresponding to amino acids 265-471 and 55-471, respectively) or the entire coding part of the pneumolysin gene were fused to the promoter and signal sequence-coding region of the alpha-amylase gene of Bacillus amyloliquefaciens. The C-terminal fusion peptides reacted with anti-pneumolysin serum, but were not hemolytically active. In both cases most of the peptide remained cell-associated. When the entire pneumolysin gene was fused to the signal sequence, a hemolytically active form of pneumolysin could be detected, and most of the product was found in a processed form in the culture supernatant. The full-length pneumolysin secreted from B. subtilis was partially purified and used as antigen in an enzyme immunoassay with rabbit anti-pneumolysin serum.

References

Jun 1, 1978·Molecular & General Genetics : MGG·J KreftW Goebel
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S D Ehrlich
Mar 1, 1986·Journal of General Microbiology·P KallioM Sarvas
Jan 1, 1987·The Journal of Infection·Y KerttulaP H Mäkelä
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·I PalvaL Kääriäinen
May 1, 1983·Gene·I PalvaC Weissmann
Apr 21, 1984·British Medical Journal·M R Lockley, R Wise
Jul 1, 1983·The Journal of Infectious Diseases·R M DouglasD J Hansman

❮ Previous
Next ❯

Citations

Nov 1, 1995·Clinical and Diagnostic Laboratory Immunology·A VirolainenM Leinonen
Oct 1, 1990·Current Opinion in Biotechnology·G Rapoport, A Klier
Jan 15, 1992·European Journal of Biochemistry·J M Sanchez-PuellesE Garcia
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·M J FerrándizA G De La Campa
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Luz BalsalobreAdela G de la Campa
Feb 5, 2005·Anais Da Academia Brasileira De Ciências·Luís C S FerreiraWolfgang Schumann
Jan 5, 2000·Clinical and Diagnostic Laboratory Immunology·J A ScottM Leinonen
Mar 1, 1993·Microbiological Reviews·M Simonen, I Palva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.